Sex, Drugs and Market Expansion
Executive Summary
Schering-Plough figures its deal with Zonagen gives them a relatively cheap way of getting into the potentially huge erectile dysfunction market that Pfizer and Astra AB/Vivus will bear the brunt of the costs of creating.